Where Are They Now? | GenomeWeb

Where Are They Now?


In Genome Technology one year ago, we looked at pharmacogenomics and how it was being integrated into the pharma pipeline. George Poste, former chief science and technology officer at GlaxoSmithKline and current CEO of Health Technology Networks, graced the cover as the first pharma exec to sign a major genomics deal, back in 1993 with Human Genome Sciences.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.